Global X HealthTech ETF (NASDAQ:HEAL – Get Free Report) saw a significant increase in short interest during the month of January. As of January 15th, there was short interest totaling 25,312 shares, an increase of 227.0% from the December 31st total of 7,741 shares. Approximately 1.9% of the shares of the stock are short sold. Based on an average daily volume of 22,171 shares, the short-interest ratio is presently 1.1 days. Based on an average daily volume of 22,171 shares, the short-interest ratio is presently 1.1 days. Approximately 1.9% of the shares of the stock are short sold.
Institutional Investors Weigh In On Global X HealthTech ETF
Several hedge funds have recently added to or reduced their stakes in the company. AE Wealth Management LLC purchased a new position in shares of Global X HealthTech ETF in the 3rd quarter worth about $34,000. Banque Cantonale Vaudoise bought a new stake in Global X HealthTech ETF in the 3rd quarter worth approximately $37,000. Glenmede Investment Management LP bought a new position in Global X HealthTech ETF during the third quarter valued at approximately $31,000. Daiwa Securities Group Inc. bought a new position in Global X HealthTech ETF during the third quarter valued at approximately $11,239,000. Finally, Raymond James Financial Inc. purchased a new position in shares of Global X HealthTech ETF during the third quarter worth approximately $274,000.
Global X HealthTech ETF Stock Performance
Global X HealthTech ETF stock traded down $0.40 during mid-day trading on Friday, hitting $28.45. 5,221 shares of the company traded hands, compared to its average volume of 13,096. Global X HealthTech ETF has a one year low of $24.48 and a one year high of $35.73. The stock has a market cap of $37.84 million, a price-to-earnings ratio of 42.80 and a beta of 1.13. The stock has a fifty day moving average price of $30.40 and a 200-day moving average price of $31.19.
Global X HealthTech ETF Dividend Announcement
Global X HealthTech ETF Company Profile
An ETF that invests in companies at the intersection of healthcare and technology, targeting innovations in drug discovery, medical devices, consumer healthcare, and analytics.
See Also
- Five stocks we like better than Global X HealthTech ETF
- What a Former CIA Agent Knows About the Coming Collapse
- Buy This Stock at 9:30 AM on MONDAY!
- Nvidia CEO Issues Bold Tesla Call
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- Market Panic: Trump Just Dropped a Bomb on Your Stocks
Receive News & Ratings for Global X HealthTech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global X HealthTech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
